10 Best European Stocks To Buy According to Billionaires

6. Medtronic plc (NYSE:MDT)

Number of Billionaires: 14

Medtronic plc (NYSE:MDT) is a global leader in medical technology, offering a wide range of products and therapies that address various health conditions. Its portfolio includes cardiac devices like pacemakers and defibrillators, insulin pumps for diabetes management, surgical instruments, and neurostimulation devices. Operating across cardiovascular, medical-surgical, neuroscience, and diabetes segments, Medtronic serves healthcare systems and patients worldwide.

In the second quarter of fiscal year 2025, ending October 25, 2024, Medtronic plc (NYSE:MDT) reported revenue of $8.403 billion, a 5.3% increase from the previous year. This growth was driven by strong performances in its cardiovascular and neuroscience portfolios, which saw revenue increases of 6.1% and 7.1%, respectively.

Despite these positive results, Medtronic plc (NYSE:MDT) faced challenges in its medical-surgical unit, which experienced a 0.4% revenue decline due to shifts in U.S. distributor buying patterns. Additionally, foreign currency fluctuations negatively impacted earnings, with the company reporting a $104 million currency impact.

Analysts remain optimistic about Medtronic’s future, citing its strong product pipeline, including innovations in surgical robotics and diabetes devices. As of March 14, 2025, Medtronic plc (NYSE:MDT) is trading at $93.16, reflecting a 0.83% increase from the previous close. The stock rose 7.7% in 2025.